2985, cedar Brook drive

Decatur GA 30033

Global Biosimilars Market 2020 and Forecast 2029

Global Biosimilars Market 2020 and Forecast 2029

Published Date : 01-June-2020 | Pages : 200+ | Included Covid – 19 Impacted Analysis

Description

We, at CRR, have always studied the market in-depth and have been doing the pressure testing since our inception. Given the current pandemic situation, we all are of consensus that it is a constant now. Owing to which, the report addresses COVID-19 effects on this market too.

Key Companies :
Pfizer
Sandoz International GmbH
Teva Pharmaceuticals Industries
Amgen Inc
Biocon
Dr. Reddy’s Laboratories
F. Hoffmann-La Roche
Celltrion
Samsung Bioepis

Market by Type :
Recombinant Non-glycosylated Proteins (Insulin
rHGH
Interferon)
Glycosylated (mAb
EPO)
Peptides (Glucagon
Calcitonin)
Peptides (Glucagon
Calcitonin)

Market by Application :
Oncology
Blood Disorders

By Region :
Asia-Pacific: China, Southeast Asia, India, Japan, Korea, Oceania
Europe : Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland
North America : United States, Canada, Mexico
Middle East & Africa : GCC, North Africa, South Africa
South America : Brazil, Argentina, Columbia, Chile, Peru

In this study, the years considered to estimate the market size of report are as follows:
History Year: 2013-2018
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2029
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Additional information

Select License

,

TOC

Chapter 1 Global Biosimilars Market Overview
1.1 Introduction
1.2 Taxonomy
1.2.1 By Product Type & End User
1.2.2 By Region
1.3 Drivers for Biosimilars Market
1.4 Restraints for Biosimilars Market
1.5 Opportunities for Biosimilars Market
1.6 Trends for Biosimilars Market
1.7 COVID-19 Impact Assessment on Biosimilars Industry
1.8 Macro-economic Factors
1.9 Regulatory Framework
1.10 Pricing Analysis by Region, 2020
1.11 Opportunity Map Analysis
1.12 Opportunity Orbits
1.13 Market Investment Feasibility Index
1.14 PEST Analysis
1.15 PORTERS Five Force Analysis
1.16 Go to Market Strategy
1.17 Value Chain Analysis
1.18 Cost Structure Analysis
1.19 Regional Market Share and BPS Analysis

Chapter 2 Global Biosimilars Market Overview
2.1 Global Biosimilars Market by Product Type
2.1.1 Global Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
2.1.2 Global Biosimilars Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
2.1.3 Global Biosimilars Market Attractiveness Analysis by Product Type, (2013-2020)
2.2 Global Biosimilars Market by End User
2.2.1 Global Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
2.2.2 Global Biosimilars Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
2.2.3 Global Biosimilars Market Attractiveness Analysis by End User, (2013-2020)
2.3 Global Biosimilars Market by Region
2.3.1 Global Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
2.3.2 Global Biosimilars Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
2.3.3 Global Biosimilars Market Attractiveness Analysis by Region, (2013-2020)
2.4 Global Biosimilars Market Outlook (2013-2029)
2.4.1 Global Biosimilars Market Value (US$ Mn) and Volume (Units) (2013-2020)
2.4.2 Global Biosimilars Market Value (US$ Mn) and Volume (Units) (2021-2029)
2.5 Global Biosimilars Market Value (US$ Mn) and Volume (Units) by Regions
2.5.1 Global Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
2.5.2 Global Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
2.6 Global Biosimilars Market Value (US$ Mn) and Volume (Units) by Product Type
2.6.1 Global Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
2.6.2 Global Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
2.7 Global Biosimilars Market Value (US$ Mn) and Volume (Units) by End User
2.7.1 Global Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
2.7.2 Global Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
2.8 Global Biosimilars Market Y-o-Y Growth Rate Comparison (2014-2029)
2.8.1 Global Biosimilars Market Y-o-Y Growth Rate by Region
2.8.2 Global Biosimilars Market Y-o-Y Growth Rate by Product Type
2.8.3 Global Biosimilars Market Y-o-Y Growth Rate by End User
2.9 Global Biosimilars Market Share Comparison (2013-2029)
2.9.1 Global Biosimilars Market Share by Region
2.9.2 Global Biosimilars Market Share by Product Type
2.9.3 Global Biosimilars Market Share by End User

Chapter 3 North America Biosimilars Market Overview
3.1 North America Biosimilars Market by Product Type
3.1.1 North America Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
3.1.2 North America Biosimilars Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
3.1.3 North America Biosimilars Market Attractiveness Analysis by Product Type, (2013-2020)
3.2 North America Biosimilars Market by End User
3.2.1 North America Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
3.2.2 North America Biosimilars Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
3.2.3 North America Biosimilars Market Attractiveness Analysis by End User, (2013-2020)
3.3 North America Biosimilars Market by Region
3.3.1 North America Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
3.3.2 North America Biosimilars Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
3.3.3 North America Biosimilars Market Attractiveness Analysis by Region, (2013-2020)
3.4 North America Biosimilars Market Outlook (2013-2029)
3.4.1 North America Biosimilars Market Value (US$ Mn) and Volume (Units) (2013-2020)
3.4.2 North America Biosimilars Market Value (US$ Mn) and Volume (Units) (2021-2029)
3.5 North America Biosimilars Market Value (US$ Mn) and Volume (Units) by Regions
3.5.1 North America Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
3.5.2 North America Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
3.6 North America Biosimilars Market Value (US$ Mn) and Volume (Units) by Product Type
3.6.1 North America Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
3.6.2 North America Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
3.7 North America Biosimilars Market Value (US$ Mn) and Volume (Units) by End User
3.7.1 North America Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
3.7.2 North America Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
3.8 North America Biosimilars Market Y-o-Y Growth Rate Comparison (2014-2029)
3.8.1 North America Biosimilars Market Y-o-Y Growth Rate by Region
3.8.2 North America Biosimilars Market Y-o-Y Growth Rate by Product Type
3.8.3 North America Biosimilars Market Y-o-Y Growth Rate by End User
3.9 North America Biosimilars Market Share Comparison (2013-2029)
3.9.1 North America Biosimilars Market Share by Region
3.9.2 North America Biosimilars Market Share by Product Type
3.9.3 North America Biosimilars Market Share by End User

Chapter 4 Europe Biosimilars Market Overview
4.1 Europe Biosimilars Market by Product Type
4.1.1 Europe Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
4.1.2 Europe Biosimilars Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
4.1.3 Europe Biosimilars Market Attractiveness Analysis by Product Type, (2013-2020)
4.2 Europe Biosimilars Market by End User
4.2.1 Europe Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
4.2.2 Europe Biosimilars Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
4.2.3 Europe Biosimilars Market Attractiveness Analysis by End User, (2013-2020)
4.3 Europe Biosimilars Market by Region
4.3.1 Europe Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
4.3.2 Europe Biosimilars Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
4.3.3 Europe Biosimilars Market Attractiveness Analysis by Region, (2013-2020)
4.4 Europe Biosimilars Market Outlook (2013-2029)
4.4.1 Europe Biosimilars Market Value (US$ Mn) and Volume (Units) (2013-2020)
4.4.2 Europe Biosimilars Market Value (US$ Mn) and Volume (Units) (2021-2029)
4.5 Europe Biosimilars Market Value (US$ Mn) and Volume (Units) by Regions
4.5.1 Europe Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
4.5.2 Europe Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
4.6 Europe Biosimilars Market Value (US$ Mn) and Volume (Units) by Product Type
4.6.1 Europe Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
4.6.2 Europe Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
4.7 Europe Biosimilars Market Value (US$ Mn) and Volume (Units) by End User
4.7.1 Europe Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
4.7.2 Europe Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
4.8 Europe Biosimilars Market Y-o-Y Growth Rate Comparison (2014-2029)
4.8.1 Europe Biosimilars Market Y-o-Y Growth Rate by Region
4.8.2 Europe Biosimilars Market Y-o-Y Growth Rate by Product Type
4.8.3 Europe Biosimilars Market Y-o-Y Growth Rate by End User
4.9 Europe Biosimilars Market Share Comparison (2013-2029)
4.9.1 Europe Biosimilars Market Share by Region
4.9.2 Europe Biosimilars Market Share by Product Type
4.9.3 Europe Biosimilars Market Share by End User

Chapter 5 Asia Pacific Biosimilars Market Overview
5.1 Asia Pacific Biosimilars Market by Product Type
5.1.1 Asia Pacific Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
5.1.2 Asia Pacific Biosimilars Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
5.1.3 Asia Pacific Biosimilars Market Attractiveness Analysis by Product Type, (2013-2020)
5.2 Asia Pacific Biosimilars Market by End User
5.2.1 Asia Pacific Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
5.2.2 Asia Pacific Biosimilars Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
5.2.3 Asia Pacific Biosimilars Market Attractiveness Analysis by End User, (2013-2020)
5.3 Asia Pacific Biosimilars Market by Region
5.3.1 Asia Pacific Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
5.3.2 Asia Pacific Biosimilars Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
5.3.3 Asia Pacific Biosimilars Market Attractiveness Analysis by Region, (2013-2020)
5.4 Asia Pacific Biosimilars Market Outlook (2013-2029)
5.4.1 Asia Pacific Biosimilars Market Value (US$ Mn) and Volume (Units) (2013-2020)
5.4.2 Asia Pacific Biosimilars Market Value (US$ Mn) and Volume (Units) (2021-2029)
5.5 Asia Pacific Biosimilars Market Value (US$ Mn) and Volume (Units) by Regions
5.5.1 Asia Pacific Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
5.5.2 Asia Pacific Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
5.6 Asia Pacific Biosimilars Market Value (US$ Mn) and Volume (Units) by Product Type
5.6.1 Asia Pacific Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
5.6.2 Asia Pacific Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
5.7 Asia Pacific Biosimilars Market Value (US$ Mn) and Volume (Units) by End User
5.7.1 Asia Pacific Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
5.7.2 Asia Pacific Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
5.8 Asia Pacific Biosimilars Market Y-o-Y Growth Rate Comparison (2014-2029)
5.8.1 Asia Pacific Biosimilars Market Y-o-Y Growth Rate by Region
5.8.2 Asia Pacific Biosimilars Market Y-o-Y Growth Rate by Product Type
5.8.3 Asia Pacific Biosimilars Market Y-o-Y Growth Rate by End User
5.9 Asia Pacific Biosimilars Market Share Comparison (2013-2029)
5.9.1 Asia Pacific Biosimilars Market Share by Region
5.9.2 Asia Pacific Biosimilars Market Share by Product Type
5.9.3 Asia Pacific Biosimilars Market Share by End User

Chapter 6 South America Biosimilars Market Overview
6.1 South America Biosimilars Market by Product Type
6.1.1 South America Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
6.1.2 South America Biosimilars Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
6.1.3 South America Biosimilars Market Attractiveness Analysis by Product Type, (2013-2020)
6.2 South America Biosimilars Market by End User
6.2.1 South America Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
6.2.2 South America Biosimilars Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
6.2.3 South America Biosimilars Market Attractiveness Analysis by End User, (2013-2020)
6.3 South America Biosimilars Market by Region
6.3.1 South America Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
6.3.2 South America Biosimilars Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
6.3.3 South America Biosimilars Market Attractiveness Analysis by Region, (2013-2020)
6.4 South America Biosimilars Market Outlook (2013-2029)
6.4.1 South America Biosimilars Market Value (US$ Mn) and Volume (Units) (2013-2020)
6.4.2 South America Biosimilars Market Value (US$ Mn) and Volume (Units) (2021-2029)
6.5 South America Biosimilars Market Value (US$ Mn) and Volume (Units) by Regions
6.5.1 South America Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
6.5.2 South America Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
6.6 South America Biosimilars Market Value (US$ Mn) and Volume (Units) by Product Type
6.6.1 South America Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
6.6.2 South America Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
6.7 South America Biosimilars Market Value (US$ Mn) and Volume (Units) by End User
6.7.1 South America Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
6.7.2 South America Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
6.8 South America Biosimilars Market Y-o-Y Growth Rate Comparison (2014-2029)
6.8.1 South America Biosimilars Market Y-o-Y Growth Rate by Region
6.8.2 South America Biosimilars Market Y-o-Y Growth Rate by Product Type
6.8.3 South America Biosimilars Market Y-o-Y Growth Rate by End User
6.9 South America Biosimilars Market Share Comparison 2013-2029
6.9.1 South America Biosimilars Market Share by Region
6.9.2 South America Biosimilars Market Share by Product Type
6.9.3 South America Biosimilars Market Share by End User

Chapter 7 MEA Biosimilars Market Overview
7.1 MEA Biosimilars Market by Product Type
7.1.1 MEA Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
7.1.2 MEA Biosimilars Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
7.1.3 MEA Biosimilars Market Attractiveness Analysis by Product Type, (2013-2020)
7.2 MEA Biosimilars Market by End User
7.2.1 MEA Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
7.2.2 MEA Biosimilars Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
7.2.3 MEA Biosimilars Market Attractiveness Analysis by End User, (2013-2020)
7.3 MEA Biosimilars Market by Region
7.3.1 MEA Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
7.3.2 MEA Biosimilars Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
7.3.3 MEA Biosimilars Market Attractiveness Analysis by Region, (2013-2020)
7.4 MEA Biosimilars Market Outlook (2013-2029)
7.4.1 MEA Biosimilars Market Value (US$ Mn) and Volume (Units) (2013-2020)
7.4.2 MEA Biosimilars Market Value (US$ Mn) and Volume (Units) (2021-2029)
7.5 MEA Biosimilars Market Value (US$ Mn) and Volume (Units) by Regions
7.5.1 MEA Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
7.5.2 MEA Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
7.6 MEA Biosimilars Market Value (US$ Mn) and Volume (Units) by Product Type
7.6.1 MEA Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
7.6.2 MEA Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
7.7 MEA Biosimilars Market Value (US$ Mn) and Volume (Units) by End User
7.7.1 MEA Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
7.7.2 MEA Biosimilars Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
7.8 MEA Biosimilars Market Y-o-Y Growth Rate Comparison (2014-2029)
7.8.1 MEA Biosimilars Market Y-o-Y Growth Rate by Region
7.8.2 MEA Biosimilars Market Y-o-Y Growth Rate by Product Type
7.8.3 MEA Biosimilars Market Y-o-Y Growth Rate by End User
7.9 MEA Biosimilars Market Share Comparison (2013-2029)
7.9.1 MEA Biosimilars Market Share by Region
7.9.2 MEA Biosimilars Market Share by Product Type
7.9.3 MEA Biosimilars Market Share by End User

Chapter 8 Global Biosimilars Market Company Profiles
8.1 Market Competition Scenario Analysis, By Company
8.2 Competitor Landscape
8.3 Company Share Analysis
8.4 Company Profiles
8.4.1
8.4.1.1 Company Overview
8.4.1.2 Business Description
8.4.1.3 Product Portfolio
8.4.1.4 Key Financials
8.4.1.5 Key Developments
8.4.1.6 SWOT Analysis…
Pfizer
Sandoz International GmbH
Teva Pharmaceuticals Industries
Amgen Inc
Biocon
Dr. Reddy’s Laboratories
F. Hoffmann-La Roche
Celltrion
Samsung Bioepis

Chapter 9 Methodology and Data Source
9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources

$ 3900$ 7800

  • Corporate Price
  • Individual Price
Clear

For More Information

Email us at:

sales@credenceresearchreports.com

Call us at:

+1-925-478-7203